SIGN UP
LOG IN
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga·07/18/2025 12:07:40
Listen to the news
Gainers
- Telomir Pharmaceuticals (NASDAQ:TELO) shares rose 151.2% to $3.04 during Friday's pre-market session. The market value of their outstanding shares is at $36.0 million.
- Mesoblast (NASDAQ:MESO) shares moved upwards by 26.09% to $15.56. The company's market cap stands at $1.5 billion.
- Innate Pharma (NASDAQ:IPHA) shares rose 15.22% to $2.04. The market value of their outstanding shares is at $163.1 million.
- Windtree Therapeutics (NASDAQ:WINT) stock increased by 14.28% to $1.2. The market value of their outstanding shares is at $12.1 million.
- TAO Synergies (NASDAQ:TAOX) stock moved upwards by 13.4% to $10.66. The market value of their outstanding shares is at $13.0 million.
- Alterity Therapeutics (NASDAQ:ATHE) stock rose 12.14% to $5.17. The market value of their outstanding shares is at $68.2 million.
Losers
- Sarepta Therapeutics (NASDAQ:SRPT) shares fell 25.3% to $16.42 during Friday's pre-market session. The market value of their outstanding shares is at $2.1 billion.
- Calidi Biotherapeutics (AMEX:CLDI) stock decreased by 15.36% to $0.52. The company's market cap stands at $21.2 million.
- 180 Life Sciences (NASDAQ:ATNF) stock fell 14.21% to $1.57. The market value of their outstanding shares is at $11.0 million.
- Vera Therapeutics (NASDAQ:VERA) stock declined by 12.93% to $20.69. The company's market cap stands at $1.5 billion.
- Redhill Biopharma (NASDAQ:RDHL) shares declined by 12.81% to $2.11. The company's market cap stands at $5.5 million.
- Metsera (NASDAQ:MTSR) stock fell 11.98% to $38.99. The market value of their outstanding shares is at $4.6 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.